NTSR1 and neoplasm: Biodistribution analysis indicated a high tumor-to-muscle ratio (12.34 ± 1.32) at 1 h after injection, identifying 68Ga-DOTA-NT-20.3 as a promising PET tracer for imaging NTR1-expressing tumors.